Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 11, 2014, Pages 2087-2095

  Shen, Long ^a   Qin, Kunhua ^a   Wang, Dekun ^a   Zhang, Yan ^a   Bai, Nan ^a   Yang, Shengyong ^b   Luo, Yunping ^c   Xiang, Rong ^a   Tan, Xiaoyue ^a  

^a NANKAI UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Beijing Union Medical School   (China)

Author keywords

Breast cancer; E cadherin; Metastasis; Oct4; Rnd1

Indexed keywords

GUANOSINE TRIPHOSPHATASE; OCTAMER TRANSCRIPTION FACTOR 4; RND1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LAMELLIPODIUM; LUCIFERASE ASSAY; LUNG NODULE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA SEQUENCE; TRANSCRIPTION INITIATION;

EID: 84908004021     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.07.015     Document Type: Article

References (35)

1. Wood S.L., Westbrook J.A., Brown J.E. Omic-profiling in breast cancer metastasis to bone: implications for mechanisms, biomarkers and treatment. Cancer Treat. Rev. 2014, 40:139-152.
2. Xiang R., Liao D., Cheng T., Zhou H., Shi Q., Chuang T.H., Markowitz D., Reisfeld R.A., Luo Y. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br. J. Cancer 2011, 104:1931. (vol 104, pg 1410, 2011).
3. Liu H., Radisky D.C., Yang D., Xu R., Radisky E.S., Bissell M.J., Bishop J.M. MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits. Nat. Cell Biol. 2012, 14:567-574.
4. Dai X., Ge J., Wang X., Qian X., Zhang C., Li X. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncol. Rep. 2013, 29:155-160.
5. Chen Z., Xu W.R., Qian H., Zhu W., Bu X.F., Wang S., Yan Y.M., Mao F., Gu H.B., Cao H.L., Xu X.J. Oct4, a novel marker for human gastric cancer. J. Surg. Oncol. 2009, 99:414-419.
6. Lu Y., Zhu H., Shan H., Lu J., Chang X., Li X., Lu J., Fan X., Zhu S., Wang Y., Guo Q., Wang L., Huang Y., Zhu M., Wang Z. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett. 2013, 340:113-123.
7. 2+ influx in breast cancer cells. Biochem. Biophys. Res. Commun. 2011, 411:786-791.
8. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., Harris C.C., McLellan M.D., Fulton R.S., Fulton L.L., Abbott R.M., Hoog J., Dooling D.J., Koboldt D.C., Schmidt H., Kalicki J., Zhang Q., Chen L., Lin L., Wendl M.C., McMichael J.F., Magrini V.J., Cook L., McGrath S.D., Vickery T.L., Appelbaum E., Deschryver K., Davies S., Guintoli T., Crowder R., Tao Y., Snider J.E., Smith S.M., Dukes A.F., Sanderson G.E., Pohl C.S., Delehaunty K.D., Fronick C.C., Pape K.A., Reed J.S., Robinson J.S., Hodges J.S., Schierding W., Dees N.D., Shen D., Locke D.P., Wiechert M.E., Eldred J.M., Peck J.B., Oberkfell B.J., Lolofie J.T., Du F., Hawkins A.E., O'Laughlin M.D., Bernard K.E., Cunningham M., Elliott G., Mason M.D., Thompson D.M., Ivanovich J.L., Goodfellow P.J., Perou C.M., Weinstock G.M., Aft R., Watson M., Ley T.J., Wilson R.K., Mardis E.R. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005.
9. Nijkamp M.M., Span P.N., Hoogsteen I.J., van der Kogel A.J., Kaanders J.H., Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother. Oncol. 2011, 99:344-348.
10. Mays R.W., Nelson W.J., Marrs J.A. Generation of epithelial cell polarity: roles for protein trafficking, membrane-cytoskeleton, and E-cadherin-mediated cell adhesion. Cold Spring Harb. Symp. Quant. Biol. 1995, 60:763-773.
11. van Roy F., Berx G. The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 2008, 65:3756-3788.
12. Fan L., Wang H., Xia X., Rao Y., Ma X., Ma D., Wu P., Chen G. Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression. Oncol. Lett. 2012, 4:1225-1233.
13. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., He W., Chen J., Li F., Zhuang Q., Qin B., Xu J., Li W., Yang J., Gan Y., Qin D., Feng S., Song H., Yang D., Zhang B., Zeng L., Lai L., Esteban M.A., Pei D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
14. Zhou J., Li K., Gu Y., Feng B., Ren G., Zhang L., Wang Y., Nie Y., Fan D. Transcriptional up-regulation of RhoE by hypoxia-inducible factor (HIF)-1 promotes epithelial to mesenchymal transition of gastric cancer cells during hypoxia. Biochem. Biophys. Res. Commun. 2011, 415:348-354.
15. Riou P., Villalonga P., Ridley A.J. Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression. Bioessays 2010, 32:986-992.
16. Goda T., Takagi C., Ueno N. Xenopus Rnd1 and Rnd3 GTP-binding proteins are expressed under the control of segmentation clock and required for somite formation. Dev. Dyn. 2009, 238:2867-2876.
17. Oinuma I., Kawada K., Tsukagoshi K., Negishi M. Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation. Mol. Biol. Cell 2012, 23:1593-1604.
18. Zhou Y., Li S., Huang Q., Xie L., Zhu X. Nanog suppresses cell migration by downregulating thymosin beta4 and Rnd3. J. Mol. Cell Biol. 2013, 5:239-249.
19. Wennerberg K., Forget M.A., Ellerbroek S.M., Arthur W.T., Burridge K., Settleman J., Der C.J., Hansen S.H. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr. Biol. 2003, 13:1106-1115.
20. Harada A., Katoh H., Negishi M. Direct interaction of Rnd1 with FRS2 beta regulates Rnd1-induced down-regulation of RhoA activity and is involved in fibroblast growth factor-induced neurite outgrowth in PC12 cells. J. Biol. Chem. 2005, 280:18418-18424.
21. Zhang M.Yang, Chen R., Su W., Li P., Chen S., Chen Z., Chen A., Li S., Hu C. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways. Oncogene 2013, 26:3374-3382.
22. Rousseau M., Gaugler M.H., Rodallec A., Bonnaud S., Paris F., Corre I. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration. Biochem. Biophys. Res. Commun. 2011, 414:750-755.
23. Wei L., Wang L., Carson J.A., Agan J.E., Imanaka-Yoshida K., Schwartz R.J. beta1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter. FASEB J. 2001, 15:785-796.
24. Tao Q., Chen S., Xu Y., Chen Y., Li X., Mou W., Wang L., Liu Y., Reisfeld R.A., Xiang R., Lv D., Li N. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One 2012, 7:e36326.
25. Jia X.P., Li X.F., Xu Y.X., Zhang S., Mou W.J., Liu Y.H., Liu Y., Lv D., Liu C.H., Tan X.Y., Xiang R., Li N. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J. Mol. Cell Biol. 2011, 3:230-238.
26. Liu W.D., Zhang T., Wang C.L., Meng H.M., Song Y.W., Zhao Z., Li Z.M., Liu J.K., Pan S.H., Wang W.B. Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines. Oncol. Lett. 2012, 4:1315-1320.
27. Chiou S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., Chang H.T., Chen Y.S., Lin T.W., Hsu H.S., Wu C.W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70:10433-10444.
28. Oinuma K., Kawada K., Tsukagoshi M. Negishi, Rnd1 and Rnd3 targeting to lipid raft is required for p190RhoGAP activation. Mol. Biol. of the Cell. 2012, 23:1593-1604.
29. Khoury H., Dankort D.L., Sadekova S., Naujokas M.A., Muller W.J., Park M. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene 2001, 20:788-799.
30. Hanna S., El-Sibai M. Signaling networks of Rho GTPases in cell motility. Cell. Signal. 2013, 25:1955-1961.
31. Sander E.E., ten Klooster J.P., van Delft S., van der Kammen R.A., Collard J.G. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 1999, 147:1009-1022.
32. Radvak P., Repic M., Svastova E., Takacova M., Csaderova L., Strnad H., Pastorek J., Pastorekova S., Kopacek J. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells. Oncol. Rep. 2013, 29:1147-1153.
33. Reynolds A.B., Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 2004, 23:7947-7956.
34. Kim H., Oh M., Lu Q., Kim K. E-Cadherin negatively modulates delta-catenin-induced morphological changes and RhoA activity reduction by competing with p190RhoGEF for delta-catenin. Biochem. Biophys. Res. Commun. 2008, 377:636-641.
35. Bellovin D.I., Bates R.C., Muzikansky A., Rimm D.L., Mercurio A.M. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res. 2005, 65:10938-10945.